ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Comerica Incorporated Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – CMA

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Comerica Incorporated (NYSE: CMA) between February 9, 2021 and May 29, 2023, both dates inclusive (the “Class Period”), of the important October 20, 2023 lead plaintiff deadline in the securities class action commenced by the Firm.

SO WHAT: If you purchased Comerica securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Comerica class action, go to https://rosenlegal.com/submit-form/?case_id=16714 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 20, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose, among other things, that: (1) Comerica failed to provide meaningful oversight over the vendors to whom it contracted out day-to-day operations of the Direct Express program, a system through which it is contracted to provide federal benefits to millions of Americans without bank accounts; (2) as a result of violations in the day-to-day operations of Direct Express, including handling fraud disputes and allowing sensitive data to be handled out of a vendor’s office in Pakistan, Comerica was not in compliance with the Federal contract, and knew it was not in compliance; (3) Comerica knew and failed to disclose that it was in potential violation of Regulation E due to inadequate fraud prevention in the Direct Express program and responses to instances of fraud; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Comerica class action, go to https://rosenlegal.com/submit-form/?case_id=16714   or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8917865

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important September 15 Deadline in Securities Class Action – DHR

NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Danaher Corporation (NYSE: DHR) between April 21, 2022 and April 24, 2023, both dates inclusive (the “Class Period”), of the important September 15, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Danaher securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Danaher class action, go to https://rosenlegal.com/submit-form/?case_id=17717 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 15, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) as the severity of the COVID-19 pandemic subsided, revenue growth associated with Danaher’s COVID-19-related businesses was declining; (2) contrary to the Company’s prior representations to investors, revenues associated with Danaher’s non-COVID-19-related businesses were insufficient to compensate for the foregoing negative trend; (3) accordingly, Danaher overstated the Company’s ability to sustain the growth it had experienced in 2020 and 2021; (4) as a result, it was unlikely that Danaher would be able to meet its 2023 revenue forecasts; and (5) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Danaher class action, go to https://rosenlegal.com/submit-form/?case_id=17717 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8917864

ROSEN, A LEADING LAW FIRM, Encourages Hayward Holdings, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – HAYW

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hayward Holdings, Inc. (NYSE: HAYW) between March 2, 2022 and July 27, 2022, both dates inclusive (the “Class Period”), of the important October 2, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Hayward common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Hayward class action, go to https://rosenlegal.com/submit-form/?case_id=12009 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 2, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Hayward and its management had engaged in a channel-stuffing scheme designed to artificially boost Hayward’s short-term sales and earnings; (2) Hayward had flooded its channel partners with inventory that they did not want or need at a level that far outpaced then-existing consumer demand; (3) Hayward’s channel partners were suffering from an inventory glut as a result of the channel-stuffing scheme that would require a massive de-stocking in the second half of 2022; (4) Hayward’s channel-stuffing scheme had cannibalized future sales, materially impairing Hayward’s ability to sell to its customers; (5) the demand for pool equipment had slowed down, which, combined with flooding channel partners with more inventory, led to an inventory glut and the need for these channel partners to reduce inventory levels; and (6) as a result of the above, Hayward’s projected 2022 financial results were not achievable and lacked a reasonable basis in fact. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Hayward class action, go to https://rosenlegal.com/submit-form/?case_id=12009 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8917856

Investment & trade fair on agri-products processing held in the city of Zhumadian, Henan, China

ZHUMADIAN, China, Sept. 6, 2023 /Xinhua-AsiaNet/– On September 6, the 25th China Agricultural Products Processing Industry Investment and Trade Fair was held in Zhumadian City in central China’s Henan Province.

The event is hosted by China’s Ministry of Agriculture and Rural Affairs and the People’s Government of Henan Province, and is organized by the ministry and province’s related departments and the local government of Zhumadian.

Seeking to explore the potential of local agricultural specialties and promote the high-quality development of the agricultural products processing industry, the fair will arrange activities such as expo tour, opening ceremony, exhibition and business match-making.

High-quality agricultural products from all over the country and even the world are on display, and domestic advanced agricultural processing technology, machinery and equipment are also showcased in the fair.

Zhumadian, located in central Henan, is an important grain and oil production base in China, with fame like “the granary of the Central Plains”, “the oil reserve of central China” and “the Sesame Kingdom”. It has the largest oil production in China and the top vegetable and animal husbandry output in Henan.

The city’s annual grain output exceeds 8 billion kilograms, of which wheat output accounts for 1/26 of the country’s total. Zhengyang, Pingyu and Biyang in Zhumadian are respectively the largest counties in the production of peanuts, sesame and shiitake mushrooms in China.

Thanks to its rich agricultural products resources, Zhumadian has a rapidly developing agricultural products processing industry, with related enterprises’ total output value topping 220 billion yuan in 2022.

Source: 25th China Agricultural Products Processing Industry Investment and Trade Fair

Image Attachments Links:  https://iop.asianetnews.net/view-attachment?attach-id=442072

Caption: Investment & trade fair on agri-products processing was held in the city of Zhumadian, Henan, China.

Resonac Partners with Matmerize to Pioneer 6G Technology Advancement using Innovative AI Software

ATLANTA, Sept. 06, 2023 (GLOBE NEWSWIRE) — In a significant collaboration, Matmerize, Inc., a materials AI innovator, and Resonac Corporation have formed a strategic partnership aimed at revolutionizing the landscape of 6G technology. Building on the strong collaborative foundation, Resonac will leverage the power of Matmerize’s PolymRize™ AI software technology to accelerate the development of exceptional high-performance neat and composite materials for 6G technology and beyond.

In January 2023, Resonac Corporation announced plans to develop new semiconductor materials for 6G, the next-generation telecommunication system standard following 5G. With 6G set to be 100 times faster than 5G, new semiconductor materials are needed to substantially reduce the transmission loss associated with the increased communication speed. To meet this requirement, Resonac will identify optimal materials with the required characteristics through computational and Artificial Intelligence (AI) methods in a collaborative venture with Matmerize, Inc. Where manual testing using traditional techniques would demand three months to assess a single materials combination, Matmerize’s AI software, PolymRize™, reduces the time required to a single day and can evaluate up to 90 combinations within the same three-month span. The result promises to be a fusion of materials engineering and artificial intelligence, poised to redefine the development of 6G technology.

PolymRize™ harnesses Matmerize’s proprietary data or client-specific data to construct predictive models. Once built, these models rapidly predict the properties of novel, yet-to-be-synthesized polymers, composites, and formulations, complete with their associated uncertainties. The software employs automated and generative design tools to recommend ideal candidates that meet property requirements for subsequent rounds of physical experimentation. PolymRize™ thus accelerates the journey towards target materials, drastically reducing both time and costs. Moreover, it introduces a framework for data management and organization, and has emerged as a dependable digital aide for chemists and process engineers.

In a pilot initiative, Resonac evaluated Matmerize’s capabilities. Predictive models were constructed using PolymRize™ and 3rd party software for key material properties relevant to 6G technology. Properties included bandgap, dielectric constant, refractive index, glass transition temperature, and coefficient of linear expansion. The performance of PolymRizeTM and third-party models were assessed by making property predictions for identical unseen test cases. PolymRizeTM predictions consistently out-performed third-party models in speed and accuracy (see figure showing Performance of models).

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

Resonac PR: Performance models comparison

“Collaborating with Resonac on the development of 6G technology is a remarkable opportunity for Matmerize,” said Rampi Ramprasad, Co-Founder and CEO of Matmerize. “Aligned with Resonac’s vision to revolutionize next-generation technologies and powered by Matmerize’s commitment to advance AI algorithms, architectures, and virtual materials design capabilities, we are poised to usher in a new era of accelerated intelligent materials design”.

For more information on the innovative PolymRizeTM platform please visit: https://www.matmerize.com/polymrize

For Resonac’s announcement of development of new semiconductor materials for 6G
https://www.resonac.com/news/2023/03/13/2391.html

About Matmerize:

Matmerize, a recent spin-out from the Georgia Institute of Technology, is at the forefront of pioneering solutions that bridge the gap between AI and materials engineering. Matmerize’s PolymRizeTM platform utilizes virtual screening and AI algorithms to identify the most optimal materials, enabling technologists to focus their experimental efforts on the most promising options, thus significantly accelerating the materials engineering process. PolymRizeTM represents a paradigm shift in industry, propelling clients ahead of the competition and driving innovation at an unprecedented pace.

About Resonac:
The Resonac Group is a new company established as a result of the integration of the Showa Denko Group and the Showa Denko Materials Group (former Hitachi Chemical Group) in January 2023. The Group’s annual sales of semiconductor and electronic materials amount to about 400 billion yen, accounting for about 30% of the Group’s annual net sales. The Group especially has global top share of semiconductor materials for packaging process. The integration of the two companies has enabled the Resonac Group to design functions of materials as well as to develop them in-house, going all the way back to raw materials. The new trade name “RESONAC” was created as a combination of two English words, namely, the word of “RESONATE” and “C” as the first letter of CHEMISTRY. The Resonac Group will make the most of its co-creative platform, and accelerate technological innovation with semiconductor manufacturers, material manufacturers, and equipment manufacturers inside and outside Japan.

For details, please refer to our website: Resonac Holdings Corporation: https://www.resonac.com/

Contact: 
Matmerize, Inc.
https://www.matmerize.com
E: info@matmerize.com
Y: Watch Matmerize Videos on YouTube
L: Follow our LinkedIn Page

GlobeNewswire Distribution ID 8917638

Nyxoah to Participate in Upcoming Investor Conferences

Nyxoah to Participate in Upcoming Investor Conferences

Mont-Saint-Guibert, Belgium – September 5, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in two upcoming investor conferences in New York City.

Olivier Taelman, Nyxoah’s Chief Executive Officer, will deliver corporate updates at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023, at 1:30pm EST and the Baird Global Healthcare Conference on Wednesday, September 13, 2023, at 12:15pm EST. Webcasts of the presentations will be available on the Events section of Nyxoah’s Investor Relations website. The Company will also be available for 1×1 meetings with institutional investors attending the events.

Nyxoah’s Investor Presentation can be accessed on the Shareholder Information section of the Company’s Investor Relations page.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contact:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313

Attachment

GlobeNewswire Distribution ID 1000838146